{
    "code": "52026960",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026960",
    "time": "2018-05-11 03:44:48",
    "許可證字號": "衛部藥輸字第026960號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/10\/04",
    "發證日期": "105\/10\/04",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202696004",
    "中文品名": "開貝西膜衣錠500毫克",
    "英文品名": "Capecitabine Teva FIlm-Coated Tablets 500mg",
    "適應症": "1.治療轉移性大腸（結腸直腸）癌病患。2.作為第三期結腸癌患者手術後的輔助性療法。3.與DOCETAXEL併用於治療對ANTHRACYCLINE化學治療無效之局部晚期或轉移性乳癌病患。4.亦可單獨用於對紫杉醇（TAXANE）及ANTHRACYCLINE化學治療無效，或無法使用ANTHRACYCLINE治療之局部晚期或轉移性乳癌病患。5.合併PLAINUM可使用於晚期胃癌之第一線治療。",
    "劑型": "116膜衣錠",
    "包裝": "20-1000粒以下ALU-PVC-PE-PVDC鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "CAPECITABINE"
    ],
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "620102K944  香港商艾維斯有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F490002000  TEVA CZECH INDUSTRIES S.R.O.",
        "製造廠廠址": "OSTRAVSKA 29, C. P. 305, 747 70 OPAVA-KOMAROV,CZECH REPUBLIC",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200037200",
            "成分名稱": "CAPECITABINE",
            "含量描述": "",
            "含量": "500.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020269600003_Capecitabin FC Tabs 500mg-中文仿單-105-11-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026960&Seq=001&Type=9"
        },
        {
            "title": "020269600002_Capecitabin FC Tabs 500mg-鋁箔-105-11-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026960&Seq=002&Type=8"
        }
    ]
}